Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

Vecchio AC, Marra CM, Schouten J, Jiang H, Kumwenda J, Supparatpinyo K, Hakim J, Sacktor N, Campbell TB, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firnhaber C, Hosseinipour MC, Mngqibisa R, Hall C, Cinque P, Robertson K.

Clin Infect Dis. 2019 Aug 12. pii: ciz745. doi: 10.1093/cid/ciz745. [Epub ahead of print]

PMID:
31630166
2.

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.

Campbell LM, Fennema-Notestine C, Saloner R, Hussain M, Chen A, Franklin D, Umlauf A, Ellis RJ, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, McCutchan JA, Letendre S, Grant I, Heaton RK; CHARTER Group.

J Int Neuropsychol Soc. 2019 Oct 2:1-16. doi: 10.1017/S1355617719000985. [Epub ahead of print]

PMID:
31576785
3.

Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis.

Marra CM, Maxwell CL, Sahi SK, Tantalo LC, Dunaway SB, Lukehart SA.

Clin Infect Dis. 2019 Sep 27. pii: ciz943. doi: 10.1093/cid/ciz943. [Epub ahead of print]

PMID:
31560366
4.

Neurosyphilis.

Gonzalez H, Koralnik IJ, Marra CM.

Semin Neurol. 2019 Aug;39(4):448-455. doi: 10.1055/s-0039-1688942. Epub 2019 Sep 18.

PMID:
31533185
5.

Neurosyphilis Treatment Outcomes After Intravenous Penicillin G versus Intramuscular Procaine Penicillin Plus Oral Probenecid.

Dunaway SB, Maxwell CL, Tantalo LC, Sahi SK, Marra CM.

Clin Infect Dis. 2019 Aug 23. pii: ciz795. doi: 10.1093/cid/ciz795. [Epub ahead of print]

PMID:
31504293
6.

Genomic epidemiology of syphilis reveals independent emergence of macrolide resistance across multiple circulating lineages.

Beale MA, Marks M, Sahi SK, Tantalo LC, Nori AV, French P, Lukehart SA, Marra CM, Thomson NR.

Nat Commun. 2019 Jul 22;10(1):3255. doi: 10.1038/s41467-019-11216-7.

7.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Grant I, Letendre SL; CHARTER Group.

Lancet HIV. 2019 Jul;6(7):e456-e462. doi: 10.1016/S2352-3018(19)30143-2. Epub 2019 Jun 14.

8.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.

Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre SL, Collier AC, Clifford DB, Gelman BB, Marra CM, McCutchan JA, Morgello S, Sacktor N, Jeste DV, Grant I, Heaton RK, Moore DJ; CHARTER and HNRP Groups.

J Int Neuropsychol Soc. 2019 May;25(5):507-519. doi: 10.1017/S1355617719000018. Epub 2019 Mar 20.

9.

High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children.

Benki-Nugent SF, Martopullo I, Laboso T, Tamasha N, Wamalwa DC, Tapia K, Langat A, Maleche-Obimbo E, Marra CM, Bangirana P, Boivin MJ, John-Stewart GC.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):102-109. doi: 10.1097/QAI.0000000000001979.

PMID:
30768490
10.

Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.

Robertson KR, Jiang H, Kumwenda J, Supparatpinyo K, Marra CM, Berzins B, Hakim J, Sacktor N, Campbell TB, Schouten J, Mollan K, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firhnhaber C, Murphy R, Hall C, Marcus C, Naini L, Masih R, Hosseinipour MC, Mngqibisa R, Badal-Faesen S, Yosief S, Vecchio A, Nair A; AIDS Clinical Trials Group.

Clin Infect Dis. 2019 May 2;68(10):1733-1738. doi: 10.1093/cid/ciy767.

11.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D, Connor JR, Hulgan T; CHARTER Study Group.

Mol Neurobiol. 2019 May;56(5):3808-3818. doi: 10.1007/s12035-018-1329-9. Epub 2018 Sep 12.

PMID:
30209774
12.

Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction.

Robertson KR, Oladeji B, Jiang H, Kumwenda J, Supparatpinyo K, Campbell TB, Hakim J, Tripathy S, Hosseinipour MC, Marra CM, Kumarasamy N, Evans S, Vecchio A, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, Firnhaber C, Price R, Marcus C, Berzins B, Masih R, Lalloo U, Sanne I, Yosief S, Walawander A, Nair A, Sacktor N, Hall C; 5199 Study Team; and the AIDS Clinical Trials Group.

Clin Infect Dis. 2019 May 2;68(10):1739-1746. doi: 10.1093/cid/ciy718.

13.

Centers for Disease Control and Prevention Syphilis Summit: Difficult Clinical and Patient Management Issues.

Marra CM, Ghanem KG.

Sex Transm Dis. 2018 Sep;45(9S Suppl 1):S10-S12. doi: 10.1097/OLQ.0000000000000851. Review.

PMID:
30102680
14.

CDC Syphilis Summit: Difficult Clinical and Patient Management Issues.

Marra CM, Ghanem K.

Sex Transm Dis. 2018 Apr 10. doi: 10.1097/OLQ.0000000000000851. [Epub ahead of print]

PMID:
29642120
15.

Other central nervous system infections: cytomegalovirus, Mycobacterium tuberculosis, and Treponema pallidum.

Marra CM.

Handb Clin Neurol. 2018;152:151-166. doi: 10.1016/B978-0-444-63849-6.00012-8. Review.

PMID:
29604973
16.

Central nervous system infection with Toxoplasma gondii.

Marra CM.

Handb Clin Neurol. 2018;152:117-122. doi: 10.1016/B978-0-444-63849-6.00009-8. Review.

PMID:
29604970
17.

Research advances in neurological infections in 2017.

Marra CM.

Lancet Neurol. 2018 Jan;17(1):18-19. doi: 10.1016/S1474-4422(17)30409-X. Epub 2017 Dec 16. No abstract available.

PMID:
29262996
18.

How Well Do Neurologic Symptoms Identify Individuals With Neurosyphilis?

Davis AP, Stern J, Tantalo L, Sahi S, Holte S, Dunaway S, Marra CM.

Clin Infect Dis. 2018 Jan 18;66(3):363-367. doi: 10.1093/cid/cix799.

19.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK.

J Int Neuropsychol Soc. 2018 Feb;24(2):163-175. doi: 10.1017/S1355617717000832. Epub 2017 Sep 6.

20.

Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.

Ho EL, Maxwell CL, Dunaway SB, Sahi SK, Tantalo LC, Lukehart SA, Marra CM.

Clin Infect Dis. 2017 Sep 15;65(6):943-948. doi: 10.1093/cid/cix473.

21.

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.

Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss CS, Heaton RK, Ellis RJ, Schork N, Marra CM, Collier AC, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, McCutchan JA, Barnholtz-Sloan JS, Franklin DR, Rosario D, Letendre SL, Grant I, Kallianpur AR; CHARTER Study Group.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):413-426. doi: 10.1002/ajmg.b.32530. Epub 2017 Apr 26.

22.

Cerebrospinal Fluid Treponema pallidum Particle Agglutination Assay for Neurosyphilis Diagnosis.

Marra CM, Maxwell CL, Dunaway SB, Sahi SK, Tantalo LC.

J Clin Microbiol. 2017 Jun;55(6):1865-1870. doi: 10.1128/JCM.00310-17. Epub 2017 Apr 5.

23.

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.

Mehta SR, Pérez-Santiago J, Hulgan T, Day TR, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, Suben JD, Franklin D, Rosario D, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur J, McCutchan A, Morgello S, Simpson D, Connor J, Grant I, Kallianpur A.

J Neuroinflammation. 2017 Mar 31;14(1):72. doi: 10.1186/s12974-017-0848-z.

24.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

Anderson AM, Muñoz-Moreno JA, McClernon DR, Ellis RJ, Cookson D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Franklin DR, Heaton RK, Grant I, Letendre SL; CHARTER Group.

J Infect Dis. 2017 Jan 1;215(1):105-113. doi: 10.1093/infdis/jiw505. Epub 2016 Oct 26.

25.

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.

Obermeit LC, Beltran J, Casaletto KB, Franklin DR, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Collier AC, Marra CM, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2017 Feb;23(1):67-78. doi: 10.1007/s13365-016-0474-z. Epub 2016 Aug 24.

26.

Macrolide Resistance in Treponema pallidum Correlates With 23S rDNA Mutations in Recently Isolated Clinical Strains.

Molini BJ, Tantalo LC, Sahi SK, Rodriguez VI, Brandt SL, Fernandez MC, Godornes CB, Marra CM, Lukehart SA.

Sex Transm Dis. 2016 Sep;43(9):579-83. doi: 10.1097/OLQ.0000000000000486.

27.

Molecular Typing of Treponema pallidum in Ocular Syphilis.

Oliver S, Sahi SK, Tantalo LC, Godornes C, Neblett Fanfair R, Markowitz LE, Lukehart SA, Marra CM.

Sex Transm Dis. 2016 Aug;43(8):524-7. doi: 10.1097/OLQ.0000000000000478.

28.

Syphilis Screening in Neurology.

Marra CM.

JAMA Neurol. 2016 Aug 1;73(8):926-7. doi: 10.1001/jamaneurol.2016.1955. No abstract available.

PMID:
27273549
29.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.

Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JA, Letendre S, Ellis R, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Ances BM; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2016 Oct;22(5):607-614. Epub 2016 Mar 28.

30.

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271.

Robertson K, Jiang H, Evans SR, Marra CM, Berzins B, Hakim J, Sacktor N, Silva MT, Campbell TB, Nair A, Schouten J; 5271 study team, Kumwenda J, Supparatpinyo K, Tripathy S, Kumarasamy N, la Rosa A, Montano S, Mwafongo A, Firnhaber C, Sanne I, Naini L, Amod F, Walawander A; AIDS Clinical Trials Group.

J Neurovirol. 2016 Aug;22(4):472-8. doi: 10.1007/s13365-015-0415-2. Epub 2016 Jan 5.

31.

Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study.

Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, Mcarthur JC; CHARTER Group.

J Neurovirol. 2016 Aug;22(4):479-87. doi: 10.1007/s13365-015-0416-1. Epub 2016 Jan 4.

32.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I; CHARTER Study Group.

J Infect Dis. 2016 Apr 1;213(7):1065-73. doi: 10.1093/infdis/jiv754. Epub 2015 Dec 21.

33.

Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia.

Fazeli PL, Moore DJ, Franklin DR, Umlauf A, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor NC, Morgello S, Simpson DM, McCutchan JA, Grant I, Letendre SL.

Curr HIV Res. 2016;14(4):324-30.

34.

Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.

Marra CM, Tantalo LC, Sahi SK, Dunaway SB, Lukehart SA.

J Infect Dis. 2016 Apr 15;213(8):1348-54. doi: 10.1093/infdis/jiv591. Epub 2015 Dec 9.

35.

Neurosyphilis.

Marra CM.

Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1714-28. doi: 10.1212/CON.0000000000000250. Review.

PMID:
26633785
36.

Prevalence Estimates of Complicated Syphilis.

Dombrowski JC, Pedersen R, Marra CM, Kerani RP, Golden MR.

Sex Transm Dis. 2015 Dec;42(12):702-4. doi: 10.1097/OLQ.0000000000000368. Review.

PMID:
26562700
37.

A Cluster of Ocular Syphilis Cases - Seattle, Washington, and San Francisco, California, 2014-2015.

Woolston S, Cohen SE, Fanfair RN, Lewis SC, Marra CM, Golden MR.

MMWR Morb Mortal Wkly Rep. 2015 Oct 16;64(40):1150-1. doi: 10.15585/mmwr.mm6440a6. No abstract available.

38.

Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.

Ma Q, Vaida F, Wong J, Sanders CA, Kao YT, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, Morgello S, Simpson DM, Heaton RK, Grant I, Letendre SL; CHARTER Group.

J Neurovirol. 2016 Apr;22(2):170-8. doi: 10.1007/s13365-015-0382-7. Epub 2015 Sep 25.

39.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

Hulgan T, Samuels DC, Bush W, Ellis RJ, Letendre SL, Heaton RK, Franklin DR, Straub P, Murdock DG, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Kallianpur AR; CHARTER Group.

Clin Infect Dis. 2015 Nov 1;61(9):1476-84. doi: 10.1093/cid/civ527. Epub 2015 Jun 30.

40.

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.

Anderson AM, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Letendre SL; CHARTER Group.

J Neurovirol. 2015 Oct;21(5):559-67. doi: 10.1007/s13365-015-0359-6. Epub 2015 Jun 12.

41.

HIV-associated neurocognitive disorders and central nervous system drug penetration: what next?

Marra CM.

Antivir Ther. 2015;20(4):365-7. doi: 10.3851/IMP2951. Epub 2015 Mar 17.

PMID:
25781980
42.

Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy.

Malvar J, Vaida F, Sanders CF, Atkinson JH, Bohannon W, Keltner J, Robinson-Papp J, Simpson DM, Marra CM, Clifford DB, Gelman B, Fan J, Grant I, Ellis RJ; CHARTER Group.

Pain. 2015 Apr;156(4):731-9. doi: 10.1097/01.j.pain.0000461252.75089.bf.

43.

Reply to Haddow et al.

Heaton RK, Franklin DR Jr, Deutsch R, Letendre SL, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I; CHARTER Group.

Clin Infect Dis. 2015 May 1;60(9):1442-3. doi: 10.1093/cid/civ045. Epub 2015 Feb 2. No abstract available.

44.

Point-of-care treponemal tests for neurosyphilis diagnosis.

Ho EL, Tantalo LC, Jones T, Sahi SK, Marra CM.

Sex Transm Dis. 2015 Jan;42(1):48-52. doi: 10.1097/OLQ.0000000000000222.

45.

Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.

Clifford DB, Vaida F, Kao YT, Franklin DR, Letendre SL, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Grant I, Heaton RK; CHARTER Group.

Neurology. 2015 Jan 20;84(3):241-50. doi: 10.1212/WNL.0000000000001156. Epub 2014 Dec 10.

46.

Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation.

Sattler FR, He J, Letendre S, Wilson C, Sanders C, Heaton R, Ellis R, Franklin D, Aldrovandi G, Marra CM, Clifford D, Morgello S, Grant I, McCutchan JA; CHARTER Group.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):281-8. doi: 10.1097/QAI.0000000000000458.

47.

Psychometric validation of the BDI-II among HIV-positive CHARTER study participants.

Hobkirk AL, Starosta AJ, De Leo JA, Marra CM, Heaton RK, Earleywine M; CHARTER Group.

Psychol Assess. 2015 Jun;27(2):457-66. doi: 10.1037/pas0000040. Epub 2014 Nov 24.

48.

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.

Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I; CHARTER Group.

Clin Infect Dis. 2015 Feb 1;60(3):473-80. doi: 10.1093/cid/ciu862. Epub 2014 Oct 31.

49.

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.

Kallianpur AR, Jia P, Ellis RJ, Zhao Z, Bloss C, Wen W, Marra CM, Hulgan T, Simpson DM, Morgello S, McArthur JC, Clifford DB, Collier AC, Gelman BB, McCutchan JA, Franklin D, Samuels DC, Rosario D, Holzinger E, Murdock DG, Letendre S, Grant I; CHARTER Study Group.

PLoS One. 2014 Aug 21;9(8):e103123. doi: 10.1371/journal.pone.0103123. eCollection 2014.

50.

The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.

Hammond ER, Crum RM, Treisman GJ, Mehta SH, Marra CM, Clifford DB, Morgello S, Simpson DM, Gelman BB, Ellis RJ, Grant I, Letendre SL, McArthur JC; CHARTER Group.

Am J Epidemiol. 2014 Aug 1;180(3):297-307. doi: 10.1093/aje/kwu098. Epub 2014 Jun 24.

Supplemental Content

Loading ...
Support Center